Berlin \/ Munich \/ Paris, Octo\u00adber 02, 2023 \u2014 Kranus Health, the digi\u00adtal health company specia\u00adli\u00adzing in thera\u00adpeu\u00adtic concepts in urology, announ\u00adces an expan\u00adsion of its Series A to a total of $15 million. The finan\u00adcing round is led by new inves\u00adtor Swiss\u00adHe\u00adalth Ventures and exis\u00adting inves\u00adtor Karista. All other exis\u00adting backers (HTGF, Wenvest and A Round Capi\u00adtal) also parti\u00adci\u00adpa\u00adted again in the finan\u00adcing. With the new capi\u00adtal, Kranus Health, foun\u00added in 2020, is now one of the best-funded health tech start\u00adups in Germany. The funds will be used prima\u00adrily for internationalization.<\/p>\n
Kranus Health mission is to revo\u00adlu\u00adtio\u00adnize the field of urology, with the help of tech\u00adno\u00adlo\u00adgi\u00adcal inno\u00adva\u00adtions. The main goal is to faci\u00adli\u00adtate access to effec\u00adtive thera\u00adpies for urolo\u00adgi\u00adcal dise\u00ada\u00adses. The company is ther\u00ade\u00adfore deve\u00adlo\u00adping digi\u00adtal solu\u00adti\u00adons for the treat\u00adment of a wide range of urolo\u00adgi\u00adcal diseases.<\/p>\n
\u201cDeve\u00adlo\u00adping thera\u00adpies that can be reim\u00adbur\u00adsed by health insu\u00adr\u00aders will make quality health care acces\u00adsi\u00adble and afforda\u00adble for all. Thanks to inno\u00adva\u00adtive and inte\u00adgra\u00adtive therapy approa\u00adches, Kranus Health closes the care gap in urology and offers a cause-orien\u00adted solu\u00adtion for pati\u00adents and physi\u00adci\u00adans,\u201d says Prof. Dr. Kurt Miller, former Medi\u00adcal Direc\u00adtor of the Clinic for Urology at the Charit\u00e9 in Berlin.<\/p>\n
With Kranus Edera, the company has alre\u00adady laun\u00adched the first digi\u00adtal health appli\u00adca\u00adtion (DiGA) as a fully reim\u00adb\u00adursable \u201capp on prescrip\u00adtion\u201d for the treat\u00adment of erec\u00adtion problems and their causes. A study at M\u00fcns\u00adter Univer\u00adsity Hospi\u00adtal has confirmed the thera\u00adpeu\u00adtic approach. The results of the study indi\u00adcate an impro\u00adve\u00adment in erec\u00adtile dysfunc\u00adtion and quality of life. Kranus Edara offers a scien\u00adti\u00adfi\u00adcally proven option besi\u00addes drugs like Viagra. Another product \u2014 Kranus Lutera \u2014 will also be reim\u00adb\u00adursable early next year and fills a major gap in the treat\u00adment of benign prosta\u00adtic hyper\u00adpla\u00adsia (BPH). Addi\u00adtio\u00adnal urolo\u00adgic thera\u00adpies for men and women are curr\u00adently being planned.<\/p>\n
The fresh money will now be used to expand into other markets outside Germany. Back in June, Kranus Health expan\u00added its presence in France by opening its third office in Paris. France is the second largest health\u00adcare market in the EU after Germany (esti\u00adma\u00adted at 281 billion euros).<\/p>\n
\u201cWe believe that now is the right time for digi\u00adtal health models to go global. The EU is a pioneer in inte\u00adgra\u00adted care offe\u00adrings, which are also gaining ground inter\u00adna\u00adtio\u00adnally,\u201d explains Jens N\u00f6rters\u00adh\u00e4u\u00adser, co-foun\u00adder and co-CEO of Kranus Health.<\/p>\n
Swiss\u00adHe\u00adalth Ventures<\/strong> is parti\u00adci\u00adpa\u00adting as a new inves\u00adtor. With the inde\u00adpen\u00addent Swiss\u00adHe\u00adalth Ventures AG, the Swiss health insurer CSS has crea\u00adted the neces\u00adsary struc\u00adtures to invest in inno\u00adva\u00adtive start\u00adups in the health\u00adcare sector.<\/p>\n \u201cOur belief in Kranus Heal\u00adth\u2019s approach to inte\u00adgra\u00adted urolo\u00adgic care aligns perfectly with our mission to drive trans\u00adfor\u00adma\u00adtive change in health\u00adcare and improve its acces\u00adsi\u00adbi\u00adlity and effec\u00adti\u00adve\u00adness for all,\u201d said Philo\u00admena Colat\u00adrella, CEO of CSS, on the reason for the partnership.<\/p>\n \u201cWe are very proud of the succes\u00adses of the past year: we were able to convince hundreds of urolo\u00adgists to perma\u00adnently inte\u00adgrate us into their treat\u00adment plans, helping more than thou\u00adsands of pati\u00adents. In addi\u00adtion, we have alre\u00adady secu\u00adred a phar\u00admaceu\u00adti\u00adcal part\u00adner and are actively explo\u00adring addi\u00adtio\u00adnal part\u00adner\u00adships that will lead to further growth,\u201d Thilo Klein\u00adschmidt, co-foun\u00adder and co-CEO of Kranus Health.<\/p>\n About Kranus Health One of the largest studies in the urolo\u00adgi\u00adcal sector, conduc\u00adted at M\u00fcns\u00adter Univer\u00adsity Hospi\u00adtal, has confirmed the effi\u00adcacy of this thera\u00adpeu\u00adtic approach and proven that Kranus Edera is a scien\u00adti\u00adfi\u00adcally proven alter\u00adna\u00adtive to Viagra and simi\u00adlar drugs.<\/p>\n Kranus Health was foun\u00added in 2020 under the scien\u00adti\u00adfic leader\u00adship of Prof. Dr. Kurt Miller, former Medi\u00adcal Direc\u00adtor of the Depart\u00adment of Urology at Charit\u00e9. The co-foun\u00adders and co-CEOs Jens N\u00f6rters\u00adh\u00e4u\u00adser & Thilo Klein\u00adschmidt have known each other for many years through their time toge\u00adther at McKin\u00adsey. Niko\u00adlay Dimo\u00adla\u00adrov (Celo\u00adnis, among others) comple\u00adments the four-member foun\u00adding team as Chief Tech\u00adno\u00adlogy Offi\u00adcer. The inter\u00adna\u00adtio\u00adnal team at Kranus Health now consists of more than 70 employees working at the company\u2019s sites in Munich, Berlin and Paris. Toge\u00adther with an expe\u00adri\u00aden\u00adced leader\u00adship team, the company plans to deve\u00adlop addi\u00adtio\u00adnal digi\u00adtal thera\u00adpies and expand its global foot\u00adprint to improve urology health\u00adcare worldwide.<\/p>\n
\n<\/strong>
\nKranus Health is the worl\u00add\u2019s leading provi\u00adder of inte\u00adgra\u00adted digi\u00adtal care concepts in urology. Current products include Kranus Edera, a novel treat\u00adment option for erec\u00adtile dysfunc\u00adtion, and Kranus Lutera, a therapy for prostate enlar\u00adge\u00adment. With Kranus Edera, the company has laun\u00adched the first digi\u00adtal health appli\u00adca\u00adtion (DiGA) as a fully reim\u00adb\u00adursable \u201capp on prescrip\u00adtion\u201d for the treat\u00adment of erec\u00adtion problems and their causes.<\/p>\n